RoboCare AI

RoboCare AI
Intelligent healthcare solutions for AI-assisted diagnostics, patient monitoring, and medical imaging analysis.
About
What does RoboCare AI do?
RoboCare provides deployment assurance for the robot economy, offering a standardized workflow for robot OEMs, operators, repair partners, and insurers. Their platform facilitates robot evaluation, deployment, and ongoing operations across various industries like hospitality, retail, and care. RoboCare ensures robots are brought into real-world environments with greater confidence through full-cycle deployment assurance.
Where is RoboCare AI headquartered?
RoboCare AI is headquartered in Tunis, Tunisia.
When was RoboCare AI founded?
RoboCare AI was founded in 2021.
What industry does RoboCare AI operate in?
RoboCare AI operates in HealthTech, MedTech, AI-Driven Protein Design, Digital Twin Healthcare, Computer Vision, Medical Imaging Analysis.
AI-powered platform for healthcare providers to manage patient WhatsApp messages efficiently.
AI-powered platform for personalized weight management and health coaching.
Clinical Trial Discovery by ENSCORE.
An independent research reference providing accessible, accurate, and transparent information on bioactive peptides and peptide science.
Medbytes provides doctors with a personalized platform for high-impact medical research and news in their specialty.
SYLARIS™ offers premium wearable wellness patches and clinical-grade skincare designed for effortless, intentional, and beautifully designed self-care rituals.
Provider-supervised peptide therapy, NAD+ support, and cognitive enhancement for cellular renewal, recovery, and healthy aging.
Purpose-built WordPress plugins for healthcare and the agencies that serve them.
An entrant is a company tagged HealthTech whose domain was first registered in the window, counted from registry records in the StartupHub directory. 6 of them registered in the last 30 days. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.